|
|
|
|
| LEADER |
00000pam a22000004a 4500 |
| 001 |
5544390 |
| 003 |
ICU |
| 005 |
20051115150900.0 |
| 008 |
031125s2004 enka b 001 0 eng |
| 010 |
|
|
|a 2003068578
|
| 020 |
|
|
|a 0566085208 (alk. paper)
|
| 040 |
|
|
|a DLC
|c DLC
|d DLC
|d UtOrBLW
|d OrLoB-B
|
| 042 |
|
|
|a pcc
|
| 050 |
0 |
0 |
|a HD9665.5
|b .M33 2004
|
| 082 |
0 |
0 |
|a 615/.1/0688
|2 22
|
| 090 |
|
|
|a fHD9665.5
|b .M33 2004
|
| 100 |
1 |
|
|a MacLennan, Janice.
|0 http://id.loc.gov/authorities/names/n98072640
|1 http://viaf.org/viaf/277682381
|
| 245 |
1 |
0 |
|a Brand planning for the pharmaceutical industry /
|c Janice MacLennan.
|
| 260 |
|
|
|a Aldershot, Hants, England ;
|a Burlington, VT, USA :
|b Gower,
|c c2004.
|
| 300 |
|
|
|a xii, 160 p. :
|b ill. ;
|c 31 cm.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|0 http://id.loc.gov/vocabulary/contentTypes/txt
|
| 337 |
|
|
|a unmediated
|b n
|2 rdamedia
|0 http://id.loc.gov/vocabulary/mediaTypes/n
|
| 338 |
|
|
|a volume
|b nc
|2 rdacarrier
|0 http://id.loc.gov/vocabulary/carriers/nc
|
| 504 |
|
|
|a Includes bibliographical references and index.
|
| 505 |
0 |
0 |
|g Pt. I.
|t Developing a brand plan for a new product --
|g 1.
|t Market segmentation --
|g 2.
|t External analysis : the starting point --
|g 3.
|t The internal analysis : the next step --
|g 4.
|t Joining up the thinking --
|g 5.
|t Formulating the strategy --
|g 6.
|t Developing the brand strategy --
|g 7.
|t Completing the plan --
|g Pt. II.
|t Planning for an in-line brand --
|g 8.
|t Reviewing the market size, value and competitor dynamics --
|g 9.
|t Reviewing the brand situation --
|g 10.
|t Setting new brand objectives --
|g 11.
|t Planning for implementation --
|g 12.
|t Reviewing the sales forecast --
|g 13.
|t Building the brand through effective communication --
|g 14.
|t Monitoring and controlling the implementation of the brand plan.
|
| 650 |
|
0 |
|a Drugs
|x Marketing.
|0 http://id.loc.gov/authorities/subjects/sh2005002422
|
| 650 |
|
0 |
|a Brand name products.
|0 http://id.loc.gov/authorities/subjects/sh85016403
|
| 650 |
|
0 |
|a Pharmaceutical industry.
|0 http://id.loc.gov/authorities/subjects/sh85039713
|
| 650 |
|
7 |
|a Brand name products.
|2 fast
|0 http://id.worldcat.org/fast/fst00837883
|
| 650 |
|
7 |
|a Drugs
|x Marketing.
|2 fast
|0 http://id.worldcat.org/fast/fst00898840
|
| 650 |
|
7 |
|a Pharmaceutical industry.
|2 fast
|0 http://id.worldcat.org/fast/fst01060129
|
| 901 |
|
|
|a ToCBNA
|
| 903 |
|
|
|a HeVa
|
| 035 |
|
|
|a (OCoLC)53831749
|
| 929 |
|
|
|a cat
|
| 999 |
f |
f |
|i e2b7278f-5aa3-5f8d-a9ec-7271d8170ccd
|s 472c9dbb-da47-5b83-9282-5fa83e910577
|
| 928 |
|
|
|t Library of Congress classification
|a HD9665.5 .M33 2004
|p f
|l JRL
|c JRL-Gen
|i 6499922
|
| 927 |
|
|
|t Library of Congress classification
|a HD9665.5 .M33 2004
|p f
|l JRL
|c JRL-Gen
|e CONE
|b 69922352
|i 7793196
|
